FDA Approval Advances Basal Insulin - Top_Thought_Leaders - MDSpire

FDA Approval Advances Basal Insulin

Weekly dosing reduces injection frequency vs daily regimens, with phase 3 data supporting efficacy and class-consistent safety.

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Top Thought Leaders in Dental

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Approval Advances Basal Insulin

  • by Kathryn Wighton

  • March 27, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Exploring the impact of digital care delivery for patients with diabetes and hypertension: A longitudinal qualitative study

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.